# Supernus Pharmaceuticals, Inc. (SUPN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SUPN/charts)

## P/E windows

| Window | Value |
| --- | --- |
| P/E1 | not enough history |
| P/E2 | 160.53 |
| P/E3 | 453.68 |
| P/E4 | 150.01 |
| P/E5 | 88.63 |
| P/E6 | 56.82 |
| P/E7 | 44.37 |
| P/E8 | 39.03 |
| P/E9 | 37.63 |
| P/E10 | 35.03 |
| P/E11 | 37.39 |
| P/E12 | 38.46 |
| P/E13 | 48.55 |
| P/E14 | 58.33 |
| P/E15 | 55.85 |

Widest P/E window this company has the history to fill: 15 years. Shorter windows are still computed; longer ones are left empty rather than padded.

## Other views

- [Metrics](https://sponda.capital/en/SUPN.md)
- [Fundamentals](https://sponda.capital/en/SUPN/fundamentals.md)
- [Compare](https://sponda.capital/en/SUPN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.